Recent advances in targeting tumor energy metabolism with tumor acidosis as a biomarker of drug efficacy

HIGHLIGHTS

• who: Paul J Akhenblit from the University of Arizona, Tucson, AZ, USA have published the article: Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy, in the Journal: (JOURNAL)
• what: This review will cover glucose and fatty acid metabolism PI3K/AKT/mTOR HIF-1 and glutamine pathways in energy metabolism and how they are being exploited for treatments and therapies by promising pre-clinical or clinical drugs being developed or investigated.
• future: Topotecan chemotherapy is used in the clinic to treat small cell lung cancer and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.